Overview

A Single-arm Study to Evaluate Safety and Effectiveness of VX-548 for Acute Pain

Status:
Not yet recruiting
Trial end date:
2024-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and effectiveness of VX-548 in treating acute pain.
Phase:
Phase 3
Details
Lead Sponsor:
Vertex Pharmaceuticals Incorporated